Studies into the anticancer effects of selenomethionine against human colon cancer

Mark A. Nelson, Anne Christine Goulet, Elizabeth T. Jacobs, Peter Lance

Research output: Contribution to journalArticlepeer-review

19 Scopus citations


Colorectal cancer is the third most frequent fatal malignant neoplasm in the United States and is expected to cause significant morbidity and mortality. The recent recall of cyclooxygenase-2 inhibitors from clinical trials highlights the need to develop other agents for cancer chemoprevention trials. Intervention strategies with selenium compounds represent a viable option to reduce colon cancer. Here we discuss epidemiologic studies and ongoing clinical trials with selenium. In addition, we discuss preclinical mechanistic studies that provide insights into the biochemical and molecular bases for the anticancer effects of selenomethionine.

Original languageEnglish (US)
Pages (from-to)26-32
Number of pages7
JournalAnnals of the New York Academy of Sciences
StatePublished - 2005


  • Cancer chemoprevention
  • Colon cancer
  • ERK
  • Histone H3
  • Selenomethionine

ASJC Scopus subject areas

  • General Neuroscience
  • General Biochemistry, Genetics and Molecular Biology
  • History and Philosophy of Science


Dive into the research topics of 'Studies into the anticancer effects of selenomethionine against human colon cancer'. Together they form a unique fingerprint.

Cite this